Stay updated on Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Deleted notices include a government funding status warning and the prior site revision note (v3.4.1); a new site revision (v3.4.2) has been added. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T06:14:56.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a site-wide funding/status notice and the page revision tag v3.4.1, and removed the previous v3.4.0 tag. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:19:02.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page now shows a glossary toggle and new metadata lines (Last Update Submitted that Met QC Criteria; Revision: v3.4.0; No FEAR Act Data). The older QC criterion line and the previous No FEAR Act data wording were removed or changed.
    Difference
    0.2%
    Check dated 2026-01-28T04:22:27.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Page revision label updated from v3.3.3 to v3.3.4; no changes to study content are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:01:06.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The study locations section now shows a separate 'Locations' heading with 'Ontario' listed, replacing the previous 'Ontario Locations' label. The HHS Vulnerability Disclosure link was removed and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T17:27:30.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Revision note updated from v3.2.0 to v3.3.2; no study data or content changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:33:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page.